These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 18760760)
41. Pharmaco-epidemiological considerations in patients with arthritis and vascular disease of the kidney. Bulpitt CJ Scand J Rheumatol Suppl; 1986; 62():4-13. PubMed ID: 3492036 [TBL] [Abstract][Full Text] [Related]
42. Inhibition of renal prostaglandin synthesis in man: methodological and clinical implications. Patrono C Scand J Rheumatol Suppl; 1986; 62():14-25. PubMed ID: 3099382 [TBL] [Abstract][Full Text] [Related]
53. Apparently unexplainable hypoglycemia in a diabetic patient--clue for renal failure? Jikki PN J Assoc Physicians India; 2008 Aug; 56():646-7. PubMed ID: 19051716 [No Abstract] [Full Text] [Related]
54. Can the effects of protein restriction on the progression of renal failure also be achieved by pharmacological means? Verberckmoes R; Van Renterghem Y Blood Purif; 1989; 7(1):58-60. PubMed ID: 2493259 [TBL] [Abstract][Full Text] [Related]
55. Renal toxicity of non-steroidal anti-inflammatory drugs. Black HE Toxicol Pathol; 1986; 14(1):83-90. PubMed ID: 3487106 [TBL] [Abstract][Full Text] [Related]
56. Letter by Kielstein et al regarding article, "High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid". Kielstein JT; Woywodt A; Salpeter SR Circulation; 2007 May; 115(18):e450-1; author reply e451. PubMed ID: 17485587 [No Abstract] [Full Text] [Related]
57. Prostaglandins in nephrology. Astoin M; Hornych A; Meyer P Adv Nephrol Necker Hosp; 1974; 4():139-69. PubMed ID: 4219990 [No Abstract] [Full Text] [Related]
58. Renal consequences of valvular heart disease. Porter GA; Bennett WM; Wilson JW Am J Cardiol; 1975 Jun; 35(6):886-97. PubMed ID: 1093376 [TBL] [Abstract][Full Text] [Related]
59. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition. Botha P; Parry G; Dark JH; Macgowan GA J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695 [TBL] [Abstract][Full Text] [Related]
60. Adverse cardiovascular effects of NSAIDs: driven by blood pressure, or edema? Aneja A; Farkouh ME Ther Adv Cardiovasc Dis; 2008 Feb; 2(1):53-66. PubMed ID: 19124408 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]